Biotechnology Assets S.A. (BST) — Financial Flexibility Index
Biotechnology Assets S.A. (BST) has a Financial Flexibility Index of 0.09x as of June 2025. Free cash flow of €660.12K (operating CF €658.13K minus capex €1.99K) represents 0% of total liabilities (€7.01 Million). Check financial resilience of Biotechnology Assets S.A. to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Biotechnology Assets S.A. Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Biotechnology Assets S.A. across 11 annual periods. See BST net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Biotechnology Assets S.A. (2014–2024)
Year-by-year free cash flow to debt coverage for Biotechnology Assets S.A.. For the full company profile including market capitalisation, see Biotechnology Assets S.A. (BST) total market value.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.08x | €646.88K | €-73.85K | €8.17 Million | ▲ +113.4% |
| 2023 | 0.04x | €373.71K | €47.74K | €10.08 Million | ▼ -99.7% |
| 2022 | 14.37x | €209.79 Million | €-1.73 Million | €14.60 Million | ▲ +26655.3% |
| 2021 | -0.05x | €-840.64K | €-1.50 Million | €15.54 Million | ▼ -109.6% |
| 2020 | 0.56x | €9.19 Million | €8.79 Million | €16.37 Million | ▲ +722.1% |
| 2019 | -0.09x | €-7.68 Million | €-15.16 Million | €85.11 Million | ▼ -186.2% |
| 2018 | -0.03x | €-1.83 Million | €-13.02 Million | €58.04 Million | ▼ -116.9% |
| 2017 | 0.19x | €1.78 Million | €213.49K | €9.56 Million | ▼ -75.1% |
| 2016 | 0.75x | €5.98 Million | €2.71 Million | €8.02 Million | ▲ +340.0% |
| 2015 | 0.17x | €1.23 Million | €158.16K | €7.23 Million | ▲ +251.6% |
| 2014 | 0.05x | €338.07K | €-303.79K | €7.01 Million | — |